These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3009656

  • 1. [Antagonists of platelet activating factor].
    Tokumura A, Tsukatani H.
    Seikagaku; 1985 Dec; 57(12):1618-23. PubMed ID: 3009656
    [No Abstract] [Full Text] [Related]

  • 2. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB, Lam MH, Biftu T, Beattie TR, Shen TY.
    J Biol Chem; 1985 Dec 15; 260(29):15639-45. PubMed ID: 2999126
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X, Han GQ, Li RZ.
    Proc Natl Acad Sci U S A; 1985 Feb 15; 82(3):672-6. PubMed ID: 2983307
    [Abstract] [Full Text] [Related]

  • 4. Species difference in the specific receptors of platelet activating factor.
    Hwang SB, Lam MH.
    Biochem Pharmacol; 1986 Dec 15; 35(24):4511-8. PubMed ID: 3024653
    [Abstract] [Full Text] [Related]

  • 5. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 Dec 15; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 6. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor.
    Shen TY, Hussaini IM.
    Methods Enzymol; 1990 Dec 15; 187():446-54. PubMed ID: 2172742
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists.
    Darius H, Smith JB, Lefer AM.
    Int Arch Allergy Appl Immunol; 1986 Dec 15; 80(4):369-75. PubMed ID: 3015804
    [Abstract] [Full Text] [Related]

  • 8. [Platelet activating factor].
    Deguchi K, Murashima S, Deguchi A.
    Nihon Rinsho; 1987 May 15; 45(5):1115-26. PubMed ID: 3041069
    [No Abstract] [Full Text] [Related]

  • 9. Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes.
    Lambrecht G, Parnham MJ.
    Br J Pharmacol; 1986 Feb 15; 87(2):287-9. PubMed ID: 3006857
    [Abstract] [Full Text] [Related]

  • 10. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM, Kulikov VI, Manevich EM, Muliar AG, Shvets VI.
    Farmakol Toksikol; 1988 Feb 15; 51(4):113-23. PubMed ID: 2847936
    [No Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
    Stewart AG, Grigoriadis G.
    J Lipid Mediat; 1991 Nov 15; 4(3):299-308. PubMed ID: 1662547
    [Abstract] [Full Text] [Related]

  • 12. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.
    Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY.
    Biochem Biophys Res Commun; 1985 Mar 29; 127(3):799-808. PubMed ID: 2985058
    [Abstract] [Full Text] [Related]

  • 13. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.
    Tokumura A, Yoshida J, Maruyama T, Fukuzawa K, Tsukatani H.
    Thromb Res; 1987 Apr 01; 46(1):51-63. PubMed ID: 3647677
    [Abstract] [Full Text] [Related]

  • 14. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F, Steiner E, Jouquey S, Godfroid JJ.
    J Lipid Mediat; 1989 Apr 01; 1(5):303-12. PubMed ID: 2562436
    [Abstract] [Full Text] [Related]

  • 15. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun 01; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 16. Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF.
    O'Donnell M.
    Ann N Y Acad Sci; 1991 Jun 01; 629():416-8. PubMed ID: 1659287
    [No Abstract] [Full Text] [Related]

  • 17. [Function of platelet activating factor in asthma].
    Ukena D, Sybrecht GW.
    Dtsch Med Wochenschr; 1988 Oct 21; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct 21; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z, Imura Y, Nishikawa K, Sumida S.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Oct 21; 15():715-7. PubMed ID: 3004156
    [No Abstract] [Full Text] [Related]

  • 20. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M, Delaunois A, Gustin P, Godeau JM, Lekeux P.
    Vet Res; 2000 Oct 21; 31(2):267-72. PubMed ID: 10779205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.